MedPath

Sodium Sulfacetamide 10 % and Sulfur 2 % Cleanser

Sodium Sulfacetamide 10% - Sulfur 2%

Approved
Approval ID

480b4c92-45a1-4ac8-83ee-791abf1b8759

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 3, 2023

Manufacturers
FDA

SOHM, Inc

DUNS: 009303848

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Sulfacetamide and Sulfur

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50405-851
Product Classification
G
Generic Name
Sodium Sulfacetamide and Sulfur
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 3, 2023
FDA Product Classification

INGREDIENTS (20)

SULFACETAMIDE SODIUMActive
Quantity: 100 mg in 1 g
Code: 4NRT660KJQ
Classification: ACTIB
SULFURActive
Quantity: 20 mg in 1 g
Code: 70FD1KFU70
Classification: ACTIB
ALOE VERA LEAFInactive
Code: ZY81Z83H0X
Classification: IACT
CAMELLIA OLEIFERA LEAFInactive
Code: 5077EL0C60
Classification: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT
CETYL ALCOHOLInactive
Code: 936JST6JCN
Classification: IACT
DISODIUM OLEAMIDO MEA-SULFOSUCCINATEInactive
Code: 5M1101WGSY
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NC
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
PEG-100 STEARATEInactive
Code: YD01N1999R
Classification: IACT
GLYCERYL MONOSTEARATEInactive
Code: 230OU9XXE4
Classification: IACT
SODIUM COCOYL ISETHIONATEInactive
Code: 518XTE8493
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SODIUM METHYL COCOYL TAURATEInactive
Code: JVL98CG53G
Classification: IACT
STEARYL ALCOHOLInactive
Code: 2KR89I4H1Y
Classification: IACT
SODIUM THIOSULFATEInactive
Code: HX1032V43M
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Drug Labeling Information

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 5/3/2023

PRECAUTIONS:

**General -**If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but Sulfacetamide Sodium and Sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.

Information for patients - Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.

Carcinogenesis, Mutagenesis and Impairment of Fertility - Long-term studies in animals have not been performed to evaluate carcinogenic potential.

Pregnancy: Category C - Animal reproduction studies have not been conducted with Sulfacetamide Sodium and Sulfur lotion. It is also not known whether Sulfacetamide Sodium and Sulfur cleanser can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sulfacetamide Sodium and Sulfur cleanser should be given to a pregnant woman only if clearly needed.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 5/3/2023

HOW SUPPLIED:

Sulfacetamide Sodium 10% and Sulfur 2% cleanser is supplied in
8 oz (227 g) bottle NDC #50405-851-01

Store at 20°-25°C (68°-77°F), excursions permitted between 15°-30°C (59°-86°F). Brief exposure to temperatures up to 40° (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C(77°F); however such exposure should be minimized. Protect from freezing.

Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Sulfacetamide 10 % and Sulfur 2 % Cleanser - FDA Drug Approval Details